431 related articles for article (PubMed ID: 21304982)
21. Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controls.
Bickel M; Lassmann C; Wieters I; Doerr HW; Herrmann E; Wicker S; Brodt HR; Stephan C; Allwinn R; Jung O
HIV Clin Trials; 2013; 14(4):175-81. PubMed ID: 23924590
[TBL] [Abstract][Full Text] [Related]
22. High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).
Weinberg A; Muresan P; Fenton T; Richardson K; Dominguez T; Bloom A; Petzold E; Anthony P; Cunningham CK; Spector SA; Nachman S; Siberry GK; Handelsman E; Flynn PM;
Hum Vaccin Immunother; 2013 May; 9(5):957-68. PubMed ID: 23370281
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children.
Solares AR; Aragon CG; Pivaral RU; Prado-Cohrs D; Sales-Carmona V; Pellegrini M; Groth N
J Infect Dev Ctries; 2014 Sep; 8(9):1160-8. PubMed ID: 25212080
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
[TBL] [Abstract][Full Text] [Related]
25. Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.
Crum-Cianflone NF; Iverson E; Defang G; Blair PJ; Eberly LE; Maguire J; Ganesan A; Faix D; Duplessis C; Lalani T; Whitman T; Brandt C; Macalino G; Millar EV; Burgess T
Vaccine; 2011 Apr; 29(17):3183-91. PubMed ID: 21371580
[TBL] [Abstract][Full Text] [Related]
26. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
27. Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.
Faix DJ; Hawksworth AW; Myers CA; Hansen CJ; Ortiguerra RG; Halpin R; Wentworth D; Pacha LA; Schwartz EG; Garcia SM; Eick-Cost AA; Clagett CD; Khurana S; Golding H; Blair PJ
PLoS One; 2012; 7(4):e34581. PubMed ID: 22514639
[TBL] [Abstract][Full Text] [Related]
28. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
[TBL] [Abstract][Full Text] [Related]
29. Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults.
Vanderven HA; Barr I; Reynaldi A; Wheatley AK; Wines BD; Davenport MP; Hogarth PM; Kent SJ
Vaccine; 2020 Feb; 38(10):2368-2377. PubMed ID: 32035709
[TBL] [Abstract][Full Text] [Related]
30. Hemagglutinin-specific CD4
Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
[TBL] [Abstract][Full Text] [Related]
31. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
[TBL] [Abstract][Full Text] [Related]
32. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
[TBL] [Abstract][Full Text] [Related]
33. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
[TBL] [Abstract][Full Text] [Related]
34. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
35. Possible Impact of Yearly Childhood Vaccination With Trivalent Inactivated Influenza Vaccine (TIV) on the Immune Response to the Pandemic Strain H1N1.
Amer A; Fischer H; Li X; Asmar B
Clin Pediatr (Phila); 2016 Mar; 55(3):245-50. PubMed ID: 26159622
[TBL] [Abstract][Full Text] [Related]
36. Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand.
Chotirosniramit N; Sugandhavesa P; Aurpibul L; Thetket S; Kosashunhanan N; Supindham T; Wongkulab P; Kaewpoowat Q; Chaiklang K; Kaewthip O; Sroysuwan P; Wongthanee A; Lerdsamran H; Puthavathana P; Suparatpinyo K
Hum Vaccin Immunother; 2012 Dec; 8(12):1854-9. PubMed ID: 22906932
[TBL] [Abstract][Full Text] [Related]
37. Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine.
Van der Vliet D; Pepin S; Lambert M; Fauchoux N; Donazzolo Y; Dupuy M; Dakowski C; Denis M
Hum Vaccin; 2010 Oct; 6(10):823-8. PubMed ID: 20935517
[TBL] [Abstract][Full Text] [Related]
38. Long-term seroprotective response of trivalent seasonal influenza vaccine in HIV-infected children, regardless of immunogenicity before immunisation.
Moolasart V; Manosuthi W; Ausavapipit J; Chottanapund S; Likanonsakul S; Uttayamakul S; Srisopha S; Lerdsamran H; Puthavathana P
Int J STD AIDS; 2016 Aug; 27(9):761-8. PubMed ID: 26138900
[TBL] [Abstract][Full Text] [Related]
39. Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.
Agrati C; Gioia C; Castilletti C; Lapa D; Berno G; Puro V; Carletti F; Cimini E; Nisii C; Castellino F; Martini F; Capobianchi MR
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1606-16. PubMed ID: 22439734
[TBL] [Abstract][Full Text] [Related]
40. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G
Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
